<DOC>
	<DOCNO>NCT01056692</DOCNO>
	<brief_summary>OC0000459 reduce inflammation tissue response allergic stimuli patient asthma . This clinical trial , mildly asthmatic patient , study effect OC000459 placebo asthmatic response two known stimulant asthmatic response lung , namely cat hair , pollen house dust mite methacholine .</brief_summary>
	<brief_title>OC000459 Bronchial Allergen Challenge</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Indoleacetic Acids</mesh_term>
	<criteria>Known history asthma ( intermittent wheezing , cough , dyspnoea responsive inhale short act beta agonist ) . FEV1 &gt; 65 % predict least two occasion screen . At screen allergen challenge , decrease FEV1 ≥20 % early asthmatic reaction ≥15 % LAR allergen 3 separate occasion 310hrs post allergen , 2 must consecutive . No steroid usage past 12 week . Testing positive skin prick challenge least one follow allergen : house dust mite , pollen cat hair within previous 12 month . Non smoker minimum 6 month ; le 10 pack year history . Respiratory tract pathology allergic asthma . Lower respiratory tract infection within 4 week prior allergen challenge . Receipt prescribe OTC medication paracetamol short act inhaled beta agonist within 14 day screen first day dose period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Asthma</keyword>
	<keyword>bronchial allergen challenge</keyword>
	<keyword>sputum eosinophiilia</keyword>
</DOC>